Sera Prognostics to Present at 27th Annual Piper Jaffray

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sera Prognostics to Present at 27th Annual Piper Jaffray Healthcare Conference

SALT LAKE CITY, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer, will present at the Piper Jaffray Healthcare Conference. Dr. Critchfield’s presentation will take place at 10:30 AM ET on Wednesday, December 2, 2015 at the Lotte New York Palace Hotel in New York, NY.

About Sera Prognostics, Inc.

Sera Prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. Sera's tests are designed to help better inform the care of a mother and her unborn child during pregnancy, and potentially lead to improved health. The company has assembled a strong management team and Board of Directors with significant clinical development and women's healthcare diagnostic experience. Sera has conducted the Proteomic Assessment of Preterm Risk (PAPR) study, one of the world's largest and broadest clinical trials to validate the performance of the Company's PreTRM™ test. PAPR enrolled 5,501 patients from 11 centers across the United States, representing the diversity of the intended use population for asymptomatic singleton pregnancies. The Company is supported by a strong group of investors, including Domain Associates, InterWest Partners, Catalyst Health Ventures, The Bill and Melinda Gates Foundation, Chione, Ltd, UpStart Life Sciences Capital, and Osage University Partners. The Company is working with the Bill and Melinda Gates Foundation to translate Sera’s discoveries into technologies that benefit women and infants in underserved countries worldwide.  Sera Prognostics is located in Salt Lake City, Utah. For more information, please visit the company's website at www.seraprognostics.com.

About Preterm Birth

Globally preterm birth affects 15 million infants each year, with 1 million deaths occurring from prematurity. 1 Of the 4 million babies born annually in the U.S., approximately one in nine, or approximately 11 percent, is born prematurely. Preterm birth is defined as any birth before 37 weeks gestation, and is the leading cause of illness and death in newborns. Preterm birth is associated with a significantly increased risk of major long-term medical complications, including learning disabilities, cerebral palsy, chronic respiratory illness, intellectual disability, seizures, and vision and hearing loss. The complications from preterm birth can also extend beyond the first year of life, and can generate significant costs throughout the lives of affected children.

1 http://www.marchofdimes.org/materials/born-to...-birth.pdf

Company Contact: Andrew Sauter, CFO Sera Prognostics, Inc. info@seraprognostics.com (801) 990-0772 Media Contact for Sera Prognostics: Terri Clevenger Continuum Health Communications tclevenger@continuumhealthcom.com (203) 856-4326

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Diving Deep into the Whales' Activity with IBM Stock

Updated Category News Views 162

Understanding Recent Moves in IBM's Options Trading Recently, major financial players have made notable bullish moves concerning IBM. As we analyze the options trading history for International Business Machines, or IBM (NYSE: IBM), we uncover 12 unusual trades reflecting traders' sentiments. Trader Sentiment Breakdown Upon examining the trades, we find that 41% of the...

Continue Reading
Vestis Corporation Faces Important Lawsuit Deadline Ahead

Updated Category News Views 136

Critical Update on Vestis Corporation's Shareholder Lawsuit In a crucial development, the law firm Levi & Korsinsky has alerted investors regarding an impending deadline to participate in a class action lawsuit related to Vestis Corporation (NYSE: VSTS). This lawsuit aims to secure recoveries for investors who may have lost money due to alleged securities fraud. The lead...

Continue Reading
Equinor ASA Engages in Significant Share Buy-Back Activity

Updated Category News Views 90

Equinor ASA's Share Buy-Back Initiative Equinor ASA has recently made headlines with its latest share buy-back program, specifically the fourth tranche designated for the upcoming 2025 fiscal year. This strategic move aligns with the company's commitment to enhancing shareholder value and represents a proactive approach in managing its capital. Overview of the Buy-Back...

Continue Reading
Savoring the Flavor: QDOBA's National Burrito Day Celebration

Updated Category News Views 425

Celebrating National Burrito Day with QDOBA's Special Promotion QDOBA, a leading fast-casual Mexican restaurant, is kicking off National Burrito Day with an irresistible buy one, get one free offer, also known as "burrito insurance." This unique promotion is designed for the die-hard burrito lovers who believe that two burritos are better than one. In a fun twist, this...

Continue Reading
UK Competition Watchdog Challenges Google's Advertising Strategies

Updated Category News Views 109

UK Competition Watchdog Takes Action Against Google Recently, the UK's competition watchdog released significant findings about Google's practices in the advertising industry. The regulator has provisionally determined that Google (NASDAQ: GOOGL) has misused its dominant market position by managing both its publisher ad server and purchasing tools in a manner that...

Continue Reading